WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007517) NOVEL THIOPHENYLGLYCOSIDE DERIVATIVES, METHODS FOR PRODUCTION THEREOF, MEDICAMENTS COMPRISING SAID COMPOUNDS AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007517    International Application No.:    PCT/EP2003/006841
Publication Date: 22.01.2004 International Filing Date: 27.06.2003
Chapter 2 Demand Filed:    29.01.2004    
IPC:
C07H 17/00 (2006.01)
Applicants: AVENTIS PHARMA DEUTSCHLAND GMBH [DE/DE]; Brüningstrasse 50, 65929 Frankfurt am Main (DE)
Inventors: GLOMBIK, Heiner; (DE).
FRICK, Wendelin; (DE).
HEUER, Hubert; (DE).
KRAMER, Werner; (DE).
BRUMMERHOP, Harm; (DE).
PLETTENBURG, Oliver; (DE)
Priority Data:
102 31 370.9 11.07.2002 DE
Title (DE) NEUE THIOPHENGLYCOSIDDERIVATE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL UND DEREN VERWENDUNG
(EN) NOVEL THIOPHENYLGLYCOSIDE DERIVATIVES, METHODS FOR PRODUCTION THEREOF, MEDICAMENTS COMPRISING SAID COMPOUNDS AND USE THEREOF
(FR) NOUVEAUX DERIVES DE THIOPHENE-GLYCOSIDE, PROCEDE PERMETTANT DE LES PRODUIRE, MEDICAMENTS CONTENANT LESDITS COMPOSES ET LEUR UTILISATION
Abstract: front page image
(DE)Die Erfindung betrifft neue Thiophenglycosidderivate der Formel (I), worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträglichen Salze und Verfahren zu deren Herstellung. Die Verbindungen eignen sich z.B. als Antidiabetika.
(EN)The invention relates to novel thiophenylglycoside derivatives of formula (I), where the groups have the given meanings, the physiologically-acceptable salts and methods for production thereof. The compounds are suitable as anti-diabetics for example.
(FR)L'invention concerne de nouveaux dérivés de thiophène-glycoside de formule (I), dans laquelle les restes ont les significations mentionnées, ainsi que leurs sels physiologiquement compatibles et des procédés permettant de les produire. Lesdits composés s'utilisent par ex. comme antidiabétiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)